Humanwell Healthcare (Group) Co.,Ltd.

Shanghai Stock Exchange 600079.SS

Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure for the year ending December 31, 2023: USD -275.83 M

Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure is USD -275.83 M for the year ending December 31, 2023, a 38.86% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).
  • Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure for the year ending December 31, 2022 was USD -451.15 M, a -68.33% change year over year.
  • Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure for the year ending December 31, 2021 was USD -268.02 M, a -59.34% change year over year.
  • Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure for the year ending December 31, 2020 was USD -168.21 M, a -42.65% change year over year.
  • Humanwell Healthcare (Group) Co.,Ltd. Capital Expenditure for the year ending December 31, 2019 was USD -117.92 M, a 39.23% change year over year.
Key data
Date Capital Expenditure Free Cash Flow Depreciation And Amortization Deferred Income Tax
Market news
Loading...
Shanghai Stock Exchange: 600079.SS

Humanwell Healthcare (Group) Co.,Ltd.

CEO Mr. Xiafei Deng
IPO Date June 6, 1997
Location China
Headquarters No.666 Gaoxin Road
Employees 17,676
Sector Health Care
Industries
Description

Humanwell Healthcare (Group) Co.,Ltd. provides healthcare solutions in the Asia Pacific, North America, Africa, and internationally. The company offers anesthetic/analgesic products; women's health products for unplanned pregnancy, emergency contraception, and birth control; consumer healthcare products for women; and CNS drugs for bronchitis, migraine, dysmenorrhea, neuralgia, epilepsy, acute and chronic cerebrovascular diseases, and brain injury and peripheral vascular diseases. It also provides herbal medicines for cold and flu, rheumatoid arthritis, skin care, hepatitis, urinary tract infection, and hypomnesis; anti-infection drugs; OTC medicines for digestive disorders, cold and flu, anti-inflammation, anti-infection, and nutritional supplements; and other products targeting cardiovascular, gastrointestinal, and reproductive diseases. The company was formerly known as Wuhan Humanwell Healthcare (Group) Co., Ltd. and changed its name to Humanwell Healthcare (Group) Co.,Ltd. in March 2013. Humanwell Healthcare (Group) Co.,Ltd. was founded in 1993 and is based in Wuhan, China.

Similar companies

600085.SS

Beijing Tongrentang Co., Ltd

USD 5.16

2.25%

600066.SS

Yutong Bus Co.,Ltd.

USD 3.77

3.45%

600062.SS

China Resources Double-Crane Pharmaceutical Co.,Ltd.

USD 2.64

2.39%

600161.SS

Beijing Tiantan Biological Products Co., Ltd.

USD 2.65

1.42%

600089.SS

TBEA Co., Ltd.

USD 1.68

2.85%

StockViz Staff

January 15, 2025

Any question? Send us an email